Ahmed Aribi, Gautam Borthakur, Farhad Ravandi, Jianqin Shan, Jan Davisson, Jorge Cortes and Hagop Kantarjian Activity of decitabine, a hypomethylating agent, in chronic myelomonocytic leukemia Cancer 109
Article first published online: 11 JAN 2007 | DOI: 10.1002/cncr.22457
Decitabine, a hypomethylating agent, was given at 100 mg/m2 per course every 4 weeks to 19 patients with chronic myelomonocytic leukemia and resulted in 11 complete responses and 2 hematologic improvements, for an overall response rate of 69%.
Complete the form below and we will send an e-mail message containing a link to the selected article on your behalf
Required = Required Field